We are committed to communicating about better patient outcomes and the realignment of healthcare as we know it. We can have a positive impact by connecting patients to the new ideas, products and services that will be at the forefront of this transformation.

Carey Pilato
Senior Vice President


  • Expert in global product and corporate pharmaceutical communications
  • Diverse experience in novel biologics, biosimilars, generics, diagnostic imaging, vaccines, and medical devices
  • Extensive public policy experience including eight years working for three members of Congress and six years as a volunteer Mayor of Bound Brook, N.J.

Carey Pilato has more than 20 years of healthcare communications experience and extensive expertise in public affairs, market shaping, and brand strategy. He works out of the New Jersey office on behalf of a patient advocacy group and on a global vaccine brand for children and adults.

During the course of his career, he has played a primary role in the planning and execution of pre- and post-product launches in multiple therapeutic areas that include: oncology, cardiovascular, hematology, gastroenterology, generics, biosimilars, dermatology, infectious disease, diagnostic imaging, vaccines, wound and ostomy care, rare diseases, medical devices, asthma, and respiratory diseases. Past clients have included: Pfizer, AstraZeneca, Sanofi-aventis, ConvaTec, Sanofi-Pasteur, Novartis, Bristol Myers Squibb, BD, Amersham Health, and healthcare non-profits, such as the American Academy of Family Physicians and the American Lung Association.

As a director of communications at Pfizer, he managed strategic communications; product and issues management; and internal and external communications for 600 products in the emerging markets and established products business units including Lipitor, Norvasc, Zithromax, Geodon, Aromasin, Aricept, and Xanax. He led the ground-breaking global communications strategy and corporate issues management for the patent expiration of Lipitor, the largest selling pharmaceutical product. He also conducted global communications that supported the FDA approval and launch of Elelyso for Gaucher disease.

Carey holds a bachelor’s degree in political science from York College of Pennsylvania and a mini-MBA in social and digital media from Rutgers University.